Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene t... Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate for the treatment of arrhythmogenic cardiomyopathy; LX2021, a gene therapy candidate for the treatment of DSP cardiomyopathy associated; and LX2022, a gene therapy candidate for the treatment of HCM caused by TNNI3 mutations. It also develops LX1001, an AAVrh10-based gene therapy candidate for the treatment of APOE4 homozygous; LX1020, a gene therapy candidate for the treatment of APOE4 homozygous; LX1021 for the treatment of APOE4 homozygotes; and LX1004 for the treatment of CLN2 Batten disease. The company was incorporated in 2017 and is based in New York, New York. Mostrar más
| Período † | Variación(Ptos) | Variación % | Apertura | Precio Máximo | Precio Mínimo | Avg. Vol. diario | Precio Promedio Ponderado | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.28 | -9.65517241379 | 2.9 | 2.95 | 2.32 | 875427 | 2.55106667 | CS |
| 4 | -2.28 | -46.5306122449 | 4.9 | 5.07 | 2.32 | 499641 | 3.16433331 | CS |
| 12 | -4.22 | -61.6959064327 | 6.84 | 7.66 | 2.32 | 312129 | 4.37362897 | CS |
| 26 | -8.34 | -76.0948905109 | 10.96 | 11.72 | 2.32 | 370524 | 6.96718929 | CS |
| 52 | -13.55 | -83.7971552257 | 16.17 | 19.5 | 2.32 | 297537 | 9.69654997 | CS |
| 156 | -6.88 | -72.4210526316 | 9.5 | 22.33 | 2.32 | 249661 | 10.13997122 | CS |
| 260 | -6.88 | -72.4210526316 | 9.5 | 22.33 | 2.32 | 249661 | 10.13997122 | CS |
Parece que no se ha autenticado. Haga click al botón de abajo para iniciar la sesión y ver los símbolos recientemente consultados.
Soporte: (55) 4170 8128 | soporte@advfn.mx
Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones
Hot Features
Premium
